We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Premier Veterinary Group Plc | LSE:PVG | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 34.50 | 32.00 | 37.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMPVG
RNS Number : 0706I
Premier Veterinary Group PLC
24 August 2016
PREMIER VETERINARY GROUP PLC
("PVG" or the "Company")
Capital Reduction
Premier Veterinary Group plc announces that, further to a resolution passed by Shareholders at the Annual General Meeting held on 23 March 2016, in order to facilitate the proposed reduction of PVG's share capital (the "Capital Reduction"), full details of which were set out in the Notice of Annual General Meeting dated 28 January 2016 (the "Notice"), the Company has today issued and allotted 1,690,315 deferred shares of 90 pence each (the "Deferred Shares") to Sue Steven, the Secretary of the Company.
The deferred shares do not entitle holders to receive notice of or attend and vote at any general meeting of the Company or to receive a dividend or other distribution or to participate in any return on capital on a winding up other than the nominal amount paid on such shares following a substantial distribution to the holders of ordinary shares in the Company. Accordingly, the deferred shares are, for all practical purposes, valueless.
As set out in the Notice, the share capital of the Company will be reduced by cancelling and extinguishing both the Deferred Shares together with all other deferred shares of 90 pence each in the capital of the Company on 30 August 2016.
The Company is in the process of making an application to the High Court of Justice, Chancery Division, for approval for the reduction of PVG's share capital and cancellation of the entire amount standing to the credit of the Company's share premium account.
A further announcement will be issued in due course.
For further information, please contact:
Premier Veterinary Group plc Tel: +44 (0)117 970 4130
Dominic Tonner, Chief Executive Officer
Daniel Smith, Chief Financial Officer
Zeus Capital Limited Tel: +44 (0)203 829 5000
Giles Balleny, Director, Corporate Finance
Hugh Kingsmill Moore, Director, Sales
Square1 Consulting Tel: +44 (0)207 929 5599
David Bick/Brian Alexander
This information is provided by RNS
The company news service from the London Stock Exchange
END
CARQZLFLQVFFBBF
(END) Dow Jones Newswires
August 24, 2016 12:16 ET (16:16 GMT)
1 Year Premier Veterinary Chart |
1 Month Premier Veterinary Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
